Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Prourokinase

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 122 participants.

Also called NCT07550296

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 122 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07550296
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07550296. Randomized; single masking; primary purpose treatment. Start 2026-05-06 (actual); primary completion 2027-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours of Onset With Prourokinase
Condition
Acute Ischemic Stroke
Intervention (Drug)
prourokinase
Lead sponsor
General Hospital of Shenyang Military Region (class: other)

Record details

Record id
cardio:ct-nct07550296
Content hash
b8f62dced5bdfeb7d90cf994d3e70c275e66f1391f6799177088f66afe9a6231